Skip to main content


Columns

Pharma Insights
Andrew Cournoyer, RPh, MBA; Charline Shan, RPh, MPh; Larry Blandford, PharmD—Column Editor, June 17, 2020
Andrew Cournoyer, RPh, MBA, and colleagues explore the beginnings of Medicare Part D and the different dynamics driving…
Engaging Payers
Lili Brillstein, MPH—Column Editor, May 19, 2020
Lili Brillstein, MPH, reinforces that, to effectively and consistently optimize care, strong integrated delivery teams…
Pharma Insights
Sajjad Raza, MD, PhD, MSM; Kathy Lang, PhD, May 19, 2020
Sajjad Raza, MD, PhD, MSM, and Kathy Lang, PhD, provide evidence that the drug development landscape is evolving to a…
Trending From ACCC
JCP Editors, May 19, 2020
ACCC reviews their COVID-19 online resources, including a webcast series with episodes that focus on the “how-to” of…
Clinical Pathways GPS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, May 19, 2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD, posits that current health care tools and programs such as clinical…
Tools for Transformation
Gordon Kuntz—Column Editor, May 19, 2020
Gordon Kuntz, Partner, Kuntz Consulting, explores the long-term impacts of the pandemic on cancer care, including…
Editorial
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, April 21, 2020
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid…
Trending From ACCC
Randall A Oyer, MD, ACCC President 2020-2021, April 21, 2020
As a community-spread disease, coronavirus 2019 shows us the importance of community—from global, national, state,…
Pharma Insights
Sejal Jonas, PharmD1; Larry Blandford, PharmD2—Column Editor, April 21, 2020
Sejal Jonas, PharmD, and Larry Blandford, PharmD, describe the way that payers may view equivalars and if drug…
Clinical Pathways GPS
Matthew Pakizegee, PharmD, MS; Richard Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor; Craig Ornstein, PhD, MA; Uttama Rath, PhD, MS; Jamey Hardesty, MPH, April 21, 2020
Matthew Pakizegee, PharmD, MS, and colleagues discuss the varying roles of patients, providers, payers, policymakers,…
Back to Top